Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4518537
Max Phase: Preclinical
Molecular Formula: C24H27N3O3
Molecular Weight: 405.50
Molecule Type: Unknown
Associated Items:
ID: ALA4518537
Max Phase: Preclinical
Molecular Formula: C24H27N3O3
Molecular Weight: 405.50
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCC(=O)N[C@@H]1C(=O)N2c3ccccc3[C@@]34CCN5CC6=CCO[C@@H]1[C@@H]([C@H]23)[C@H]6C[C@H]54
Standard InChI: InChI=1S/C24H27N3O3/c1-2-18(28)25-20-21-19-14-11-17-24(8-9-26(17)12-13(14)7-10-30-21)15-5-3-4-6-16(15)27(22(19)24)23(20)29/h3-7,14,17,19-22H,2,8-12H2,1H3,(H,25,28)/t14-,17-,19-,20-,21+,22-,24+/m0/s1
Standard InChI Key: ZYQOFJMYFTVXSE-ODOYRXLASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 405.50 | Molecular Weight (Monoisotopic): 405.2052 | AlogP: 1.60 | #Rotatable Bonds: 2 |
Polar Surface Area: 61.88 | Molecular Species: BASE | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.54 | CX Basic pKa: 9.27 | CX LogP: 0.62 | CX LogD: -1.24 |
Aromatic Rings: 1 | Heavy Atoms: 30 | QED Weighted: 0.76 | Np Likeness Score: 2.06 |
1. Zlotos DP, Mohsen AMY, Mandour YM, Marzouk MA, Breitinger U, Villmann C, Breitinger HG, Sotriffer C, Jensen AA, Holzgrabe U.. (2019) 11-Aminostrychnine and N-(Strychnine-11-yl)propionamide: Synthesis, Configuration, and Pharmacological Evaluation at Glycine Receptors., 82 (8): [PMID:31385511] [10.1021/acs.jnatprod.9b00180] |
Source(1):